2020 conference on rare gynecologic tumors · amanda nickles-fader, md 2:30 q&a seoni ss nadeem...

2020CONFERENCE ON

Rare Gynecologic TumorsDecember 3-4, 2020

The University of Texas MD Anderson Cancer CenterDan L. Duncan Building (CPB)

Floor 8, Rooms 1-81155 Pressler Street

Houston, Texas

2020CONFERENCE ON

Rare Gynecologic Tumors

The 2020 Conference on Rare Gynecolog ic Tumors prov ides a gather ing for heal th care professionals who ser ve women with gynecolog ic mal ignanc ies to learn in a more int imate conference env i ronment which a l lows for in depth d iscussions of the latest data and chal lenges in the f ie ld of rare gynecolog ic oncology and a l lows for more innovat ive del iver y of the content . This act iv i t y is designed to change how prov iders manage pat ients with rare gynecolog ic tumors and wi l l a l low prov iders to bet ter care for our pat ients .

EDUCATIONAL OBJECTIVES

After attending the conference, participants should be able to:

• Incorporate latest research findings and apply to their clinical practice in terms of the role of surgery, chemotherapy, radiation and immunotherapy in treating rare gynecologic cancers with a goal of maximizing patient survival and minimizing morbidity (Knowledge, Competence, Performance, Patient Outcomes);

• Interpret side effects from second line treatment and beyond for rare gynecologic tumors (Knowledge, Competence, Performance, Patient Outcomes);

• Discover novel clinical trial design for implementing clinical trials for patients with rare gynecologic cancers (Knowledge, Competence, Performance, Patient Outcomes).

FO

CU

S

EDUCATIONAL METHODS

Lecture/Didactic, Panel Discussion, Poster Session, Abstract/Poster Presentations, Question/Answer Session

TARGET AUDIENCE

This conference should be of value to physicians, nurse practitioners, physician assistants, nurses, pharmacists, GYN residents, GYN oncology and clinical oncology fellows.

EVALUATION

A course evaluation survey will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.

ACCREDITATION/CREDIT DESIGNATION

PHYSICIANS

The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 12.50 AMA PRA Category 1 CreditsTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME CERTIFICATES AND ATTENDANCE VERIFICATION CERTIFICATES

Certificates awarding AMA PRA Category 1 CreditsTM or certificates documenting attendance will be emailed when an individual completes the online CME Verification process after the conference.

Call for AbstractsDEADLINE FOR ABSTRACT SUBMISSION IS THURSDAY, OCTOBER 1, 2020.

The Organizing Committee invites the submission of abstracts regarding clinical care or best practices in a critical care setting.

Authors may submit abstracts of completed work, work in progress, or work elsewhere within the past 12 months.

ABSTRACT SUBMISSION INSTRUCTIONS:

Abstracts will only be accepted electronically and should be uploaded to: [email protected]

The deadline for receipt of abstracts is 11:59 PM CST on Thursday, October 1, 2020. Notification of acceptance for poster presentations will be acknowledged by e-mail by October 15th, 2020.

ABSTRACT FORMATTING INSTRUCTIONS:

Limit abstracts to 300 words, one page, type in 12-point Times New Roman font, single spaced with one-inch margins, and left justified. Organize the abstract into: Background, Methods, Results, and Conclusions. Define all abbreviations. Include the abstract title, full names, and institutional affiliations of all authors, and e-mail address of the corresponding author at the top of the abstract. Underline the name of the presenting author. Abstracts must not contain copyrighted material unless permission has been obtained by the author/publisher.

ORGANIZING COMMITTEE

MICHAEL FRUMOVITZ, MD, MPH (CHAIR)Professor

Gynecologic Oncology and Reproductive Medicine

The University of Texas MD Anderson Cancer Center

Houston, Texas

MARIO LEITAO, MD (CO-CHAIR)Director

Minimal Access and Robotic Surgery

Fellowship Director

Gynecology Services

Memorial Sloan Kettering Cancer Center

New York, New York

DAVID M. GERSHENSON, MDClinical Professor



Houston, Texas

GLORIA SALVO, MDResearch Monitor

Gynecologic Oncology and Reproductive Medicine - Research


Houston, Texas

NAOMI GONZALES, MPHSenior Coordinator – Clinical Studies



Houston, Texas

ALLISON BARING, CMPCME Conference Planner

CME/Conference Management


Houston, Texas

Conference AgendaTHURSDAY, DECEMBER 3, 2020

7:00 am Registration and Continental Breakfast

8:00 Opening Remarks Michael Frumovitz, MD, MPH and Mario Leitao, MD

SESSION I : OVARYModerator: Aaron Shafer, MD

LOW GRADE SEROUS OVARIAN CANCER

8:10 Pathology M. Herman Chui, MD

8:25 Newly Diagnosed Amanda Nickles-Fader, MD

8:45 Recurrent Disease David M. Gershenson, MD

9:05 Q&A Session M. Herman Chui, MD; David M. Gershenson, MD; Amanda Nickles-Fader, MD

MUCINOUS OVARIAN CANCER

9:15 Pathology Preetha Ramalingam, MD

9:30 Translational Research Anil Sood, MD

9:50 Therapeutic Options Jennifer Mueller, MD

10:10 Q&A Session Jennifer Mueller, MD; Preetha Ramalingam, MD; Anil Sood, MD

10:30 Break

SESSION I I : OVARIAN CANCERModerator: David M. Gershenson, MD

SEX CORD STROMAL TUMORS

10:45 Translational Research Tyler Hillman, MD, PhD

11:05 Therapeutic Options Jubilee Brown, MD

11:25 Q&A Session

11:35 Tumor Board: Ovary Shannon Westin, MD, MPH

12:15 pm Lunch (provided)

SESSION I I I : UTERUSModerator: Lois M. Ramondetta, MD

UTERINE SEROUS CARCINOMA

1:30 Translational Research Samuel Mok, PhD

1:50 Newly Diagnosed Nadeem R. Abu-Rustum, MD

2:10 Recurrent Disease Amanda Nickles-Fader, MD

2:30 Q&A Session Nadeem R. Abu-Rustum, MD; Samuel Mok, PhD; Amanda Nickles-Fader, MD

SARCOMA

2:40 Leiomyosarcoma - Newly Diagnosed Martee L. Hensley, MD

3:00 Leiomyosarcoma - Recurrent Disease Pamela T. Soliman, MD

3:20 Adenosarcoma Nicole Fleming, MD

3:40 Q&A Session Nicole Fleming, MD; Martee L. Hensley, MD; Pamela T. Soliman, MD

3:50 Break

SESSION IV: UTERUSModerator: Karen H. Lu, MD

GESTATIONAL TROPHOBLASTIC DISEASE

4:10 Pathology Lora Ellenson, MD

4:25 Treatment Aaron Shafer, MD

4:45 Q&A Session

4:55 Tumor Board: Uterus Shannon Westin, MD, MPH

5:20 pm Adjourn/Reception

FRIDAY, DECEMBER 4, 2020

7:00 am Registration and Continental Breakfast

8:00 Opening Remarks Michael Frumovitz, MD, MPH and Mario Leitao, MD

ABSTRACT PRESENTATIONSModerator: Mario Leitao, MD

8:15 Abstract #1

8:25 Abstract #2

8:35 Abstract #3

8:45 Q&A Session

SESSION V: LOWER GENITAL TRACTModerator: Gloria Salvo, MD

HIGH GRADE NEUROENDOCRINE CERVIX TREATMENT

8:50 Treatment Michael Frumovitz, MD, MPH

VULVOVAGINAL MELANOMA

9:10 Newly Diagnosed Mario Leitao, MD

9:30 Recurrent Disease (Immunotherapy) Amir A. Jazaeri, MD

PAGET’S DISEASE

9:50 Treatment Michaela A. Onstad, MD

10:10 Panel Discussion

10:20 Break

RESEARCH IN RARE TUMORS

10:45 Developing Rare Tumor Registries Gloria Salvo, MD

11:05 Keynote Speaker: Challenges In Clinical Trials for Rare Tumors Robert Coleman, MD

11:50 Closing Remarks Michael Frumovitz, MD, MPH and Mario Leitao, MD

Noon Adjourn

INVITED ATTENDEES ONLY:

Noon-2:30 pm Working Lunch: Rare Tumor Collaborations – RCRs, Registries, Clinical Trials

MD ANDERSON FACULTY

MICHAEL FRUMOVITZ, MD, MPH (CHAIR)Professor

Gynecologic Oncology & Reproductive Medicine

NICOLE FLEMING, MDAssociate Professor


DAVID M. GERSHENSON, MDClinical Professor


TYLER HILLMAN, MD, PHDAssistant Professor


AMIR A. JAZAERI, MDProfessor


KAREN H. LU, MDChair


SAMUEL MOK, PHDProfessor

Gynecologic Oncology & Reproductive Medicine - Research

MICHAELA A. ONSTAD, MDAssistant Professor


PREETHA RAMALINGAM, MDProfessor

Pathology, Anatomical

LOIS M. RAMONDETTA, MDProfessor


GLORIA SALVO, MDResearch Monitor

Gynecologic Oncology & Reproductive Medicine - Research

AARON SHAFER, MDAssociate Professor


PAMELA T. SOLIMAN, MDProfessor


ANIL SOOD, MDProfessor


SHANNON WESTIN, MD, MPHAssociate Professor


GUEST FACULTY

MARIO LEITAO, MD (CO-CHAIR)Director

Minimal Access and Robotic Surgery

Fellowship Director

Gynecology Services


New York, New York

NADEEM R. ABU-RUSTUM, MDChief and Chair

Gynecology Service

Gynecologic Oncology


New York, New York

JUBILEE BROWN, MDPhysician

Obstetrics and Gynecology

Atrium Health

Levine Cancer Institute

Charlotte, North Carolina

M. HERMAN CHUI, MDPathologist

Gynecologic Pathology


New York, New York

ROBERT COLEMAN, MDChief Scientific Officer

McKesson/US Oncology

The Woodlands, Texas

LORA ELLENSON, MDDirector

Gynecologic Pathology


New York, New York

MARTEE L. HENSLEY, MDMedical Oncologist

Gynecologic Medical Oncology


New York, New York

JENNIFER MUELLER, MDSurgeon

Gynecologic Oncology


New York, New York

AMANDA NICKLES-FADER, MDVice-Chair

Gynecological Surgical Operations

Associate Professor

Gynecology and Obstetrics

Johns Hopkins Medicine

Baltimore, Maryland

REGISTRATION INFORMATION

On-site registration opens at 7:00 am on Thursday, December 3. A continental breakfast will be served. The Welcome and Opening Remarks will begin at 8:00 am and the conference will adjourn at Noon on Friday, December 4. Advanced registration is encouraged as space and materials are limited.

The deadline for advanced registration is Friday, November 6, 2020.

THERE ARE THREE WAYS TO REGISTER:

1. Online at www.mdanderson.org/conferences

2. Fax to: 713-794-1724

3. Mail to: CME/Conference Management – Unit 1781, The University of Texas MD Anderson Cancer Center, P.O. Box 301407, Houston, TX 77230-1407

WE ACCEPT THE FOLLOWING FORMS OF PAYMENT:

• Check (payable through U.S. banks only)

• Money Order

• Credit Cards (MasterCard, VISA, and American Express)

• Cash (on-site registration only)

A receipt and confirmation letter will be sent to you within ten working days of receipt of your fee. The conference registration fee includes tuition, final conference agenda, continental breakfasts, breaks, lunch and a reception. Please refer to the registration form for specific information regarding fees.

REFUND/CANCELLATION POLICY

The registration fee, minus a $50 administrative handling fee, is refundable if a written request is received on or before Friday, November 6, 2020. No refunds will be granted after that date. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check.

CME/Conference Management reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary. Each registrant will be notified by mail, e-mail, or the contact numbers as given on the registration form. In case of activity cancellation, liability of CME/Conference Management is limited to the registration fee. CME/Conference Management will refund the full registration fee.

CME/Conference Management reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available.

For additional information, please contact CME/Conference Management at 713-792-2223 or toll free at 866-849-5866.

SPECIAL ASSISTANCE

Contact CME/Conference Management at 713-792-2223 or toll-free at 866-849-5866 if you have any special dietary or ADA accommodation needs.

ACCOMMODATIONS

• A block of rooms has been reserved for conference attendees at the InterContinental Houston – Medical Center located at 6750 Main Street, Houston, Texas.

• Book your room online at: https://bit.ly/2vBwo5U

• The hotel phone number is (713) 422-2779.

• Early hotel reservation is suggested and the room block cutoff date is Monday, November 2, 2020.

• When you make reservations, be sure to mention the group name: 2020 Conference on Gynecologic Rare Tumors to be assured of receiving the special meeting rate of $159/night for a standard guest room. Please add 17% Texas state and local taxes.

GROUND TRANSPORTATION

• Houston is served by two airports, George Bush Intercontinental (IAH) and William P. Hobby (HOU). The following forms of ground transportation are available to and from both airports:

• Uber or Lyft

• Yellow Cab- 713.236.1111

The University of Texas MD Anderson Cancer Center has implemented a process whereby everyone

who is in a position to control the content of an educational activity must disclose all relevant financial

relationships with any commercial interest that could potentially affect the information presented.

MD Anderson also requires that all faculty disclose any unlabeled use or investigational use (not yet

approved for any purpose) of pharmaceutical and medical device products. Specific disclosure will be

made to the participants prior to the educational activity.

Agendas are subject to change because we are always striving to improve the quality of your

educational experience. MD Anderson may substitute faculty with comparable expertise on rare

occasions necessitated by illness, schedule conflicts, and so forth.

Photographing, audio taping and videotaping are prohibited.

CO

NFE

RE

NC

E R

EG

ISTR

ATIO

N- 1

7670

0/30

/122

003/

412

02

0 C

ON

FE

RE

NC

E O

N R

AR

E G

YN

EC

OL

OG

IC T

UM

OR

S

DE

CE

MB

ER

3-4

, 2

02

0R

EG

IST

RA

TIO

N F

EE

S

Phys

icia

ns (M

Ds/

DO

s/Ph

Ds)

o P

ostm

arke

d be

fore

Nov

embe

r 6 ..

......

......

......

......

.....

$350

o P

ostm

arke

d af

ter N

ovem

ber 6

......

......

......

......

......

....$

400

RNs,

NPs

, PA

so

Pos

tmar

ked

befo

re N

ovem

ber 6

.....

......

......

......

......

..$2

00o

Pos

tmar

ked

afte

r Nov

embe

r 6 ...

......

......

......

......

......

.$25

0

Stud

ents

/Fel

low

s/Re

side

nts

o P

ostm

arke

d be

fore

Nov

embe

r 6 ..

......

......

......

......

......

..$50

o P

ostm

arke

d af

ter N

ovem

ber 6

......

......

......

......

......

.....$

100

MD

And

erso

n Ph

ysic

ians

(MD

s/D

Os/

PhD

s) ..

......

.$20

0

MD

And

erso

n RN

s, N

Ps, P

As .

......

......

......

......

......

......

$100

Att

ende

es fr

om D

evel

opin

g Co

untr

ies .

......

......

......

..$15

0

I pla

n on

att

endi

ng th

e Th

ursd

ay, D

ec. 3

rece

ptio

n

o

Yes

o

No

Last

Nam

eFi

rst

MI

High

est D

egre

e

Depa

rtmen

t (in

clud

e un

it no

.)

Spec

ialty

Inst

itutio

n

MD

Ande

rson

Em

ploy

ee ID

No.

(req

uire

d fo

r all

MDA

CC e

mpl

oyee

s):

Phys

icia

nn

Yes

n

No

Stre

et

City

Stat

e/Fo

reig

n Co

untry

/Zip

or M

ail C

ode

Dayt

ime

Phon

e (w

ith a

rea

code

) Ce

ll Ph

one

(with

are

a co

de)

Fax

(with

are

a co

de)

E-m

ail A

ddre

ss (

plea

se p

rint)

Emer

genc

y Co

ntac

tPh

one

(with

are

a co

de)

Cred

it Ca

rd H

olde

r Nam

e (F

irst/

Last

) Ch

arge

the

follo

win

g:n

VIS

A n

MC

n

AM

EX

Cred

it Ca

rd N

umbe

rEx

pira

tion

Date

Secu

rity

Code

/CVV

/CSV

Cred

it Ca

rd H

olde

r Bill

ing

Addr

ess

& Z

IP C

ode

MD

And

erso

n In

terd

epar

tmen

tal T

rans

fer (

IDT)

No.

: *F

und

Grou

p 90

will

not

be

acce

pted

Bus

ines

s U

nit

D

epar

tmen

tFu

nd G

roup

*Fu

ndFu

nd T

ype

Aut

hori

zed

Sign

atur

e RE

QU

IRED

for C

RED

IT C

ARD

or I

DT

IDT

Appr

over

Nam

e (F

irst/L

ast)

plea

se p

rint

Dep

artm

ent

of

CM

E/C

on

fere

nce

Man

agem

ent-

Un

it 1

781

Th

e U

niv

ersi

ty o

f Te

xas

MD

An

der

son

Can

cer

Cen

ter

1767

00/3

0/12

2003

/41

PO

Bo

x 30

1407

H

ou

sto

n, T

X 7

7230

-140

7

2020 conference on rare gynecologic tumors · amanda nickles-fader, md 2:30 q&a seoni ss nadeem...

Documents